Roche Signs Up To Be Regeneron’s Global Partner For COVID Antibody

Deal Will Boost Manufacturing Of REGN-COV2

 
• By Andrew McConaghie

After failures in trials of repurposed drugs, the rivals will collaborate on Regeneron’s antibody cocktail which could prevent coronavirus infection. 

Roche
Roche: The Switzerland-headquartered firm will taken on regulatory filing outside the US, and add commercial and manufacturing capacity.

More from Business

More from Scrip